Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Burak Bilgin

Showing results (31-40 of 91) with videos related to

Pageof 10
Sort By:
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|February 14, 2015
Iatrogenic retinal breaks caused by infusion fluid during pars plana vitrectomyAhmet Burak Bilgin, Elif Betül Türkoğlu, Hatice Deniz İlhan, et al.
Eye (London, England)|March 12, 2024
Head to head comparison of diagnostic performance of three non-mydriatic cameras for diabetic retinopathy screening with artificial intelligenceMehmet Erkan Doğan, Ahmet Burak Bilgin, Ramazan Sari, et al.
Ocular Immunology and Inflammation|July 16, 2015
The Expression of GDF-15 in the Human Vitreous in the Presence of Retinal Pathologies with an Inflammatory ComponentHatice Deniz Ilhan, Ahmet Burak Bilgin, Asli Toylu, et al.
Ocular Immunology and Inflammation|April 17, 2014
Is Smoking a Risk Factor in Ocular Behçet Disease?Ahmet Burak Bilgin, Elif Betul Turkoglu, Hatice Deniz Ilhan, et al.
Current Medical Research and Opinion|January 6, 2017
Targeting the PD-1 pathway: a new hope for gastrointestinal cancersBurak Bilgin, Mehmet A N Sendur, Muhammed Bülent Akıncı, et al.
Future Oncology (London, England)|March 12, 2019
Do tyrosine kinase inhibitors lose favor in treatment of first-line metastatic renal cell carcinoma?Samet Yaman, Burak Bilgin, Mehmet An Şendur, et al.
Current Medical Research and Opinion|June 29, 2017
A current and comprehensive review of cyclin-dependent kinase inhibitors for the treatment of metastatic breast cancerBurak Bilgin, Mehmet A N Sendur, Didem Şener Dede, et al.
Future Oncology (London, England)|October 7, 2017
The current status of adjuvant treatment for high-risk renal cell carcinomaMutlu Hızal, Mehmet An Şendur, Burak Bilgin, et al.
Current Eye Research|March 5, 2014
Short-term effects of intravitreal bevacizumab on cornea and anterior chamberMete Güler, Musa Capkın, Ali Simşek, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|October 25, 2019
Expanding treatment options for resectable gastric cancer: Is it a countdown for radiotherapy?Mutlu Hizal, Mehmet Ali Sendur, Burak Bilgin, et al.
Pageof 10

Showing results (31-40 of 91) with videos related to

Sort By:
Pageof 10
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|February 14, 2015
Iatrogenic retinal breaks caused by infusion fluid during pars plana vitrectomyAhmet Burak Bilgin, Elif Betül Türkoğlu, Hatice Deniz İlhan, et al.
Eye (London, England)|March 12, 2024
Head to head comparison of diagnostic performance of three non-mydriatic cameras for diabetic retinopathy screening with artificial intelligenceMehmet Erkan Doğan, Ahmet Burak Bilgin, Ramazan Sari, et al.
Ocular Immunology and Inflammation|July 16, 2015
The Expression of GDF-15 in the Human Vitreous in the Presence of Retinal Pathologies with an Inflammatory ComponentHatice Deniz Ilhan, Ahmet Burak Bilgin, Asli Toylu, et al.
Ocular Immunology and Inflammation|April 17, 2014
Is Smoking a Risk Factor in Ocular Behçet Disease?Ahmet Burak Bilgin, Elif Betul Turkoglu, Hatice Deniz Ilhan, et al.
Current Medical Research and Opinion|January 6, 2017
Targeting the PD-1 pathway: a new hope for gastrointestinal cancersBurak Bilgin, Mehmet A N Sendur, Muhammed Bülent Akıncı, et al.
Future Oncology (London, England)|March 12, 2019
Do tyrosine kinase inhibitors lose favor in treatment of first-line metastatic renal cell carcinoma?Samet Yaman, Burak Bilgin, Mehmet An Şendur, et al.
Current Medical Research and Opinion|June 29, 2017
A current and comprehensive review of cyclin-dependent kinase inhibitors for the treatment of metastatic breast cancerBurak Bilgin, Mehmet A N Sendur, Didem Şener Dede, et al.
Future Oncology (London, England)|October 7, 2017
The current status of adjuvant treatment for high-risk renal cell carcinomaMutlu Hızal, Mehmet An Şendur, Burak Bilgin, et al.
Current Eye Research|March 5, 2014
Short-term effects of intravitreal bevacizumab on cornea and anterior chamberMete Güler, Musa Capkın, Ali Simşek, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|October 25, 2019
Expanding treatment options for resectable gastric cancer: Is it a countdown for radiotherapy?Mutlu Hizal, Mehmet Ali Sendur, Burak Bilgin, et al.
Pageof 10